Delivery Order SPE2DE21D7020-SPE2D625F6HS9
- Not listed
- Boston Scientific Corp was awarded a delivery order valued at $92,950.00 for the FARAPULSE Pulsed Field Ablation System on June 2, 2025, with an ultimate completion date of June 5, 2025. The contract is fixed-price with economic price adjustment and carries no set-aside designation. The award was funded through the Defense Health Agency's Medical Supply Chain and will be performed in Marlborough, Massachusetts, where Boston Scientific maintains its headquarters. The FARAPULSE system represents a...
- Boston Scientific Corp has been awarded a delivery order valued at $48.8K for the FARAPULSE Pulsed Field Ablation System under a fixed-price contract with economic price adjustment provisions. The contract, awarded on June 2, 2025, with an ultimate completion date of June 10, 2025, is being funded through the Defense Health Agency's Medical Supply Chain and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order represents a continuation of Boston...
- Boston Scientific Corp has been awarded a delivery order contract valued at $58,675 for the FARAPULSE Pulsed Field Ablation System, with an ultimate completion date of September 19, 2025. The award was made by the Defense Health Agency's Medical Supply Chain on September 12, 2025, with no set-aside designation. The contract utilizes fixed-price pricing with economic price adjustment terms and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order...
- Boston Scientific Corp was awarded a $84.5K delivery order by the Defense Health Agency's Medical Supply Chain on September 12, 2025, for the FARAPULSE Pulsed Field Ablation System, with an ultimate completion date of September 19, 2025. The contract employs fixed-price pricing with economic price adjustment terms and carries no set-aside designation, indicating open competition. Performance will occur at Boston Scientific's facility in Marlborough, Massachusetts, where the company...
- The U.S. Defense Health Agency's Medical Supply Chain awarded a $45,000 fixed-price delivery order to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System, effective through August 14, 2025. This delivery order, which includes economic price adjustment provisions, represents Boston Scientific's continued supply of advanced cardiac intervention technologies to the federal healthcare system. The award was made without a set-aside designation, allowing Boston Scientific to...
- The Defense Health Agency's Medical Supply Chain has awarded a $84.5K delivery order to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System, with an ultimate completion date of September 19, 2025. This fixed-price delivery order with economic price adjustment will be performed at Boston Scientific's Marlborough, Massachusetts location. The award was made without a set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The FARAPULSE...
- The Defense Health Agency's Medical Supply Chain awarded Boston Scientific Corp a $42,250 fixed-price delivery order with economic price adjustment for the FARAPULSE Pulsed Field Ablation System, with completion targeted for June 9, 2025. This delivery order, issued on June 2, 2025, represents a continuation of Boston Scientific's established role as a critical supplier of advanced cardiovascular and interventional medical devices to federal healthcare agencies. The award carries no set-aside...
- The Defense Health Agency's Medical Supply Chain awarded a $27,562 delivery order to Boston Scientific Corp on September 22, 2025, for the FARAPULSE Pulsed Field Ablation System. This fixed-price contract with economic price adjustment authority has an ultimate completion date of September 29, 2025, and will be performed at Boston Scientific's Marlborough, Massachusetts facility. The award uses no set-aside designation, indicating open competition in the federal marketplace. As a leading...
- The Defense Health Agency's Medical Supply Chain awarded a $101.4K delivery order to Boston Scientific Corp on September 22, 2025, for the FARAPULSE Pulsed Field Ablation System. This fixed-price contract with economic price adjustment authority will be completed by September 29, 2025, and performed at Boston Scientific's facility in Marlborough, Massachusetts. The contract was awarded without set-aside restrictions, allowing Boston Scientific to compete openly in the federal marketplace. As a...
- The Defense Health Agency's Medical Supply Chain issued a delivery order valued at $92,950 on August 11, 2025, to Boston Scientific Corp for the FARAPULSE Pulsed Field Ablation System. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by August 18, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. The contract utilizes no set-aside designation, allowing the award to be made through open competition. As a...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F6HS9Delivery Order
Boston Scientific Corp was awarded a $49.8K fixed-price delivery order with economic price adjustment on July 11, 2025, for the FARAPULSE Pulsed Field Ablation System. The contract is funded through the Defense Health Agency's Medical Supply Chain program and extends through July 18, 2025. The system will be delivered to Marlborough, Massachusetts, where Boston Scientific maintains its primary operations. This delivery order is not set aside for any specific business classification and represents part of Boston Scientific's broader federal healthcare technology portfolio serving defense and civilian medical supply needs. As a leading global medical technology provider, Boston Scientific supplies advanced cardiovascular and interventional medical devices to federal healthcare agencies including the Defense Health Agency and Veterans Affairs through multiple indefinite delivery vehicles and purchase orders. The FARAPULSE system, a pulsed field ablation technology, aligns with the company's specialization in innovative cardiac intervention tools and represents the continuation of Boston Scientific's critical role as a prime contractor in the federal medical device supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.8k | 7/11/25 |